One2Treat offers a paradigm shift within clinical development with a unique method of evaluation of the Net Treatment Benefit
Including multiple criteria within a single primary endpoint, our approach:
An already approved approach in multiple therapeutic areas, One2Treat’s solution ensures the medical need and potential of every product is explored in full. It showcases valuable additional treatment benefits to help strengthen both regulatory submission and post-regulatory market access.
Experience how our solution can revolutionize the holistic statistical assessment of your treatment.
Know more with less. Integrate multiple clinically relevant outcomes in your primary analysis to better leverage your data and reduce the sample size required to assess the Net Treatment Benefit.
Gain in-depth understanding of your clinical trial treatment effects.
Assess progress through interim futility analysis to refine strategies.
Leverage data to enhance future trial design decisions.
Leverage quantitative evaluations for evidence-based Health Technology Assessment (HTA) and Health Economics and Outcomes Research (HEOR), strengthening your treatment market positioning and post-marketing strategy.
Capture patient's priorities to enable comprehensive evaluation of treatment's effects, leading to meaningful insights that facilitate personalized decision-making.
At One2Treat, we are dedicated to patient-centricity, placing patient outcomes and experiences at the forefront of every study we design. We revolutionize the statistical assessment of treatment effects, consolidating all key patient-relevant outcomes into a single, comprehensive metric.
